We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$395B
AUM Growth
-$12B
Cap. Flow
-$5.37B
Cap. Flow %
-1.36%
Top 10 Hldgs %
10.91%
Holding
4,110
New
151
Increased
2,106
Reduced
1,588
Closed
95

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$895M
2
ADI icon
Analog Devices
ADI
+$737M
3
ZLAB icon
Zai Lab
ZLAB
+$472M
4
NTES icon
NetEase
NTES
+$465M
5
CSCO icon
Cisco
CSCO
+$440M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$1.48B
2
MXIM
Maxim Integrated Products
MXIM
+$898M
3
PG icon
Procter & Gamble
PG
+$567M
4
ORCL icon
Oracle
ORCL
+$478M
5
COF icon
Capital One
COF
+$459M

Sector Composition

Rank Sector Weight
1 Technology 20.29%
2 Financials 13.39%
3 Healthcare 12.62%
4 Consumer Discretionary 12.44%
5 Industrials 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STXS icon
3826
Stereotaxis
STXS
$141M
$105K ﹤0.01%
19,460
-176,003
-90% -$1.33M
TECX
3827
Tectonic Therapeutic
TECX
$550M
$105K ﹤0.01%
1,569
+154
+11% +$12.6K
ITI
3828
DELISTED
Iteris, Inc.
ITI
$105K ﹤0.01%
19,851
+5,003
+34% +$29.2K
INFI
3829
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$105K ﹤0.01%
30,832
+7,448
+32% +$23K
JWEL icon
3830
Jowell Global
JWEL
$4.04M
$104K ﹤0.01%
+1,113
New +$96.3K
NAGE
3831
Niagen Bioscience
NAGE
$276M
$104K ﹤0.01%
16,647
+4,094
+33% +$33.7K
FTFT icon
3832
Future FinTech Group
FTFT
$1.74M
$103K ﹤0.01%
61
+8
+15% +$16.1K
XNET
3833
Xunlei
XNET
$341M
$103K ﹤0.01%
36,072
+9,045
+33% +$32.2K
AMRN
3834
Amarin Corp
AMRN
$302M
$102K ﹤0.01%
996
+3
+0.3% +$295
COGT icon
3835
Cogent Biosciences
COGT
$7.32B
$102K ﹤0.01%
12,135
-717,711
-98% -$5.5M
RTB
3836
RTB Digital
RTB
$228M
$101K ﹤0.01%
+35
New +$117K
NMTR
3837
DELISTED
9 Meters Biopharma
NMTR
$101K ﹤0.01%
3,878
+1,032
+36% +$24.3K
VHC icon
3838
VirnetX Holding Corp
VHC
$56.8M
$100K ﹤0.01%
1,284
+169
+15% +$13.8K
QTT
3839
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$100K ﹤0.01%
10,057
+1,796
+22% +$25.8K
AWH
3840
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$99K ﹤0.01%
2,034
+429
+27% +$26.5K
SYRS
3841
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$97K ﹤0.01%
2,184
+363
+20% +$17.7K
KRRO icon
3842
Korro Bio
KRRO
$164M
$96K ﹤0.01%
271
+27
+11% +$10.6K
SMMT icon
3843
Summit Therapeutics
SMMT
$11B
$96K ﹤0.01%
19,167
+3,028
+19% +$21.7K
DNTH icon
3844
Dianthus Therapeutics
DNTH
$6.04B
$95K ﹤0.01%
810
+125
+18% +$14.6K
VIRX
3845
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$94K ﹤0.01%
+11,735
New +$116K
HYRE
3846
DELISTED
HyreCar Inc. Common Stock
HYRE
$94K ﹤0.01%
11,135
-633,904
-98% -$8.68M
DNN icon
3847
Denison Mines
DNN
$2.7B
$93K ﹤0.01%
62,943
JNCE
3848
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$93K ﹤0.01%
12,518
+1,370
+12% +$8.49K
BDTX icon
3849
Black Diamond Therapeutics
BDTX
$102M
$90K ﹤0.01%
+10,633
New +$105K
PRTK
3850
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$90K ﹤0.01%
18,484
+3,950
+27% +$21.8K

Similar funds

Invesco's Q3 2021 Portfolio in Review

As of Q3 2021, Invesco held 4,110 positions worth $395B, down 2.9% from $407B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Invesco's Q3 2021 filing shows 151 new, 2,106 increased, 1,588 reduced and 95 closed positions. Its largest new stake was GXO Logistics: 973,368 shares worth $76.4M. The largest sale was Alibaba, an estimated $1.48B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Invesco's largest Q3 2021 buy was GXO Logistics: 973,368 shares worth $76.4M.
  • Invesco added most to Salesforce in Q3 2021, an estimated $895M increase.
  • Invesco's biggest Q3 2021 reduction was Alibaba, cutting an estimated $1.48B.
  • Invesco fully exited Maxim Integrated Products in Q3 2021, selling an estimated $898M.
  • Invesco's ten largest holdings make up 11% of its $395B portfolio in Q3 2021.
  • Invesco opened 151 new positions and closed 95 in Q3 2021.
  • Invesco's portfolio value fell 2.9% quarter-over-quarter to $395B.

Based on Invesco's 13F filing for Q3 2021, filed 15 Nov 2021.